OSMOTICA PHARMACEUTICALS PLC's ticker is OSMT and the CUSIP is G6S41R101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,551 | -84.5% | 75,646 | 0.0% | 0.00% | -88.9% |
Q2 2023 | $42,369 | -50.9% | 75,646 | 0.0% | 0.01% | -55.0% |
Q1 2023 | $86,236 | +98.3% | 75,646 | +100.0% | 0.02% | +33.3% |
Q4 2022 | $43,496 | -44.9% | 37,823 | 0.0% | 0.02% | -51.6% |
Q3 2022 | $79,000 | +33.9% | 37,823 | 0.0% | 0.03% | +55.0% |
Q2 2022 | $59,000 | -7.8% | 37,823 | 0.0% | 0.02% | +5.3% |
Q1 2022 | $64,000 | +137.0% | 37,823 | +52.5% | 0.02% | +137.5% |
Q4 2021 | $27,000 | -40.0% | 24,800 | 0.0% | 0.01% | -38.5% |
Q3 2021 | $45,000 | -47.1% | 24,800 | 0.0% | 0.01% | -51.9% |
Q2 2021 | $85,000 | +19.7% | 24,800 | 0.0% | 0.03% | +22.7% |
Q1 2021 | $71,000 | +16.4% | 24,800 | +67.6% | 0.02% | -4.3% |
Q4 2020 | $61,000 | – | 14,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 8,148,832 | $8,801,000 | 3.14% |
Rovida Advisors Inc. | 3,000,000 | $3,210,000 | 0.14% |
Zebra Capital Management LLC | 24,384 | $26,000 | 0.04% |
TITLEIST CAPITAL, LLC | 80,184 | $87,000 | 0.02% |
Alyeska Investment Group, L.P. | 1,125,689 | $1,216,000 | 0.01% |
ArrowMark Colorado Holdings LLC | 1,000,000 | $1,080,000 | 0.01% |
Insight Advisors, LLC/ PA | 24,800 | $27,000 | 0.01% |
Engineers Gate Manager LP | 42,810 | $46,000 | 0.00% |
Renaissance Technologies | 1,355,774 | $1,464,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 249,851 | $270,000 | 0.00% |